|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q43437704
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010719.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q43437704
|
|
024
|
|
|
‡a
0000-0002-0783-1988
‡2
orcid
|
|
024
|
|
|
‡a
57208976323
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q43437704
|
|
100
|
0 |
|
‡a
Pablo Rodríguez del Río
‡9
ast
‡9
es
‡9
sl
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Pablo Rodríguez del Río
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Pablo Rodríguez del Río
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 20 Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain.
|
|
670
|
|
|
‡a
Author's 525 Bronchial Hyperresponsiveness in Children with Suggestive Asthma Symptoms
|
|
670
|
|
|
‡a
Author's Allergy to goat's and sheep's milk in a population of cow's milk-allergic children treated with oral immunotherapy.
|
|
670
|
|
|
‡a
Author's An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodology
|
|
670
|
|
|
‡a
Author's Anaphylaxis by exclusive allergy to swordfish and identification of a new fish allergen.
|
|
670
|
|
|
‡a
Author's AR101 prevents peanut allergy reactions in highly peanut-allergic children
|
|
670
|
|
|
‡a
Author's Asthma diagnosis and treatment - 1010. Lung function tests in exercise-induced asthma among pediatric population.
|
|
670
|
|
|
‡a
Author's CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
|
|
670
|
|
|
‡a
Author's Clinical contraindications to allergen immunotherapy: an EAACI position paper
|
|
670
|
|
|
‡a
Author's Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
|
|
670
|
|
|
‡a
Author's Comprehensive Review of Current Knowledge on Egg Oral Immunotherapy
|
|
670
|
|
|
‡a
Author's Contraindications to immunotherapy: a global approach
|
|
670
|
|
|
‡a
Author's Debates in allergy, regarding the symposium on: "Position Statements and Therapeutic Guidelines".
|
|
670
|
|
|
‡a
Author's Dehydrated egg white: an allergen source for improving efficacy and safety in the diagnosis and treatment for egg allergy
|
|
670
|
|
|
‡a
Author's Desquamating-nonpigmenting with onycholysis fixed drug eruption in a child due to amoxicillin. Cross-reactivity study
|
|
670
|
|
|
‡a
Author's Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children.
|
|
670
|
|
|
‡a
Author's Effect of synbiotic supplementation on children with atopic dermatitis: an observational prospective study
|
|
670
|
|
|
‡a
Author's Efficacy and safety of high-dose rush oral immunotherapy in persistent egg allergic children: A randomized clinical trial
|
|
670
|
|
|
‡a
Author's Eosinophilic esophagitis, celiac disease, and immunoglobulin E-mediated allergy in a 2-year-old child
|
|
670
|
|
|
‡a
Author's European Survey on Adverse Systemic Reactions in Allergen Immunotherapy
|
|
670
|
|
|
‡a
Author's European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
|
|
670
|
|
|
‡a
Author's "Evaluating primary endpoints in peanut immunotherapy clinical trials"
|
|
670
|
|
|
‡a
Author's Exercise-induced bronchospasm diagnosis in children. Utility of combined lung function tests
|
|
670
|
|
|
‡a
Author's Frey syndrome in children: a nonallergic cause of facial erythema triggered by food
|
|
670
|
|
|
‡a
Author's [Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey].
|
|
670
|
|
|
‡a
Author's Initial experience with carboplatin desensitization: A case series in a paediatric hospital
|
|
670
|
|
|
‡a
Author's Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis
|
|
670
|
|
|
‡a
Author's Occupational asthma caused by the inhalation of Tyrophagus putrescentiae allergens in a dry-cured ham transporter allergic to shrimp
|
|
670
|
|
|
‡a
Author's Oral immunotherapy for food allergy: a spanish guideline. Egg and Milk Immunotherapy Spanish Guide
|
|
670
|
|
|
‡a
Author's Oral immunotherapy for food allergy: a spanish guideline. Egg and Milk Immunotherapy Spanish Guide (items guide). Part II.
|
|
670
|
|
|
‡a
Author's Oral immunotherapy for food allergy: A Spanish guideline. Immunotherapy egg and milk Spanish guide (items guide). Part I: Cow milk and egg oral immunotherapy: Introduction, methodology, rationale, current state, indications contraindications and ora
|
|
670
|
|
|
‡a
Author's Oral immunotherapy in children with IgE-mediated wheat allergy: outcome and molecular changes
|
|
670
|
|
|
‡a
Author's Oral Immunotherapy to Hake in 8 Pediatric Patients
|
|
670
|
|
|
‡a
Author's Physicians' experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey.
|
|
670
|
|
|
‡a
Author's Possible eosinophilic esophagitis induced by milk oral immunotherapy
|
|
670
|
|
|
‡a
Author's Profilin, a change in the paradigm
|
|
670
|
|
|
‡a
Author's Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests
|
|
670
|
|
|
‡a
Author's Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
|
|
670
|
|
|
‡a
Author's Serious Adverse Reaction to Timolol Eye Drops in a 7-Year-Old Boy With Glaucoma and Asthma
|
|
670
|
|
|
‡a
Author's The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy
|
|
670
|
|
|
‡a
Author's The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment
|
|
909
|
|
|
‡a
(orcid) 0000000207831988
‡9
1
|
|
909
|
|
|
‡a
(scopus) 57208976323
‡9
1
|
|
919
|
|
|
‡a
earlysustainedunresponsivenessaftershortcourseeggoralimmunotherapyarandomizedcontrolledstudyineggallergicchildren
‡A
Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children.
‡9
1
|
|
919
|
|
|
‡a
20crossreactivitybetweenolivepollenand3speciesofgrassesinmadridspain
‡A
20 Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain.
‡9
1
|
|
919
|
|
|
‡a
525bronchialhyperresponsivenessinchildrenwithsuggestiveasthmasymptoms
‡A
525 Bronchial Hyperresponsiveness in Children with Suggestive Asthma Symptoms
‡9
1
|
|
919
|
|
|
‡a
allergytogoatsandsheepsmilkinapopulationofcowsmilkallergicchildrentreatedwithoralimmunotherapy
‡A
Allergy to goat's and sheep's milk in a population of cow's milk-allergic children treated with oral immunotherapy.
‡9
1
|
|
919
|
|
|
‡a
eaacieuropeansurveyonadversesystemicreactionsinallergenimmunotherapyeassithemethodology
‡A
An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodology
‡9
1
|
|
919
|
|
|
‡a
anaphylaxisbyexclusiveallergytoswordfishandidentificationofanewfishallergen
‡A
Anaphylaxis by exclusive allergy to swordfish and identification of a new fish allergen.
‡9
1
|
|
919
|
|
|
‡a
ar101preventspeanutallergyreactionsinhighlypeanutallergicchildren
‡A
AR101 prevents peanut allergy reactions in highly peanut-allergic children
‡9
1
|
|
919
|
|
|
‡a
asthmadiagnosisandtreatment1010lungfunctiontestsinexerciseinducedasthmaamongpediatricpopulation
‡A
Asthma diagnosis and treatment - 1010. Lung function tests in exercise-induced asthma among pediatric population.
‡9
1
|
|
919
|
|
|
‡a
choiceinternationalsurveyclustersofallergenimmunotherapyprescriptionfromfrenchandspanishcohorts
‡A
CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
‡9
1
|
|
919
|
|
|
‡a
clinicalcontraindicationstoallergenimmunotherapyaneaacipositionpaper
‡A
Clinical contraindications to allergen immunotherapy: an EAACI position paper
‡9
1
|
|
919
|
|
|
‡a
comparisonofinternationalsystemicadversereactionsduetoallergenimmunotherapy
‡A
Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy
‡9
1
|
|
919
|
|
|
‡a
comprehensivereviewofcurrentknowledgeoneggoralimmunotherapy
‡A
Comprehensive Review of Current Knowledge on Egg Oral Immunotherapy
‡9
1
|
|
919
|
|
|
‡a
contraindicationstoimmunotherapyaglobalapproach
‡A
Contraindications to immunotherapy: a global approach
‡9
1
|
|
919
|
|
|
‡a
debatesinallergyregardingthesymposiumonpositionstatementsandtherapeuticguidelines
‡A
Debates in allergy, regarding the symposium on: "Position Statements and Therapeutic Guidelines".
‡9
1
|
|
919
|
|
|
‡a
dehydratedeggwhiteanallergensourceforimprovingefficacyandsafetyinthediagnosisandtreatmentforeggallergy
‡A
Dehydrated egg white: an allergen source for improving efficacy and safety in the diagnosis and treatment for egg allergy
‡9
1
|
|
919
|
|
|
‡a
desquamatingnonpigmentingwithonycholysisfixeddrugeruptioninachildduetoamoxicillincrossreactivitystudy
‡A
Desquamating-nonpigmenting with onycholysis fixed drug eruption in a child due to amoxicillin. Cross-reactivity study
‡9
1
|
|
919
|
|
|
‡a
effectofsynbioticsupplementationonchildrenwithatopicdermatitisanobservationalprospectivestudy
‡A
Effect of synbiotic supplementation on children with atopic dermatitis: an observational prospective study
‡9
1
|
|
919
|
|
|
‡a
efficacyandsafetyofhighdoserushoralimmunotherapyinpersistenteggallergicchildrenarandomizedclinicaltrial
‡A
Efficacy and safety of high-dose rush oral immunotherapy in persistent egg allergic children: A randomized clinical trial
‡9
1
|
|
919
|
|
|
‡a
eosinophilicesophagitisceliacdiseaseandimmunoglobulinemediatedallergyina2yearoldchild
‡A
Eosinophilic esophagitis, celiac disease, and immunoglobulin E-mediated allergy in a 2-year-old child
‡9
1
|
|
919
|
|
|
‡a
europeansurveyonadversesystemicreactionsinallergenimmunotherapy
‡A
European Survey on Adverse Systemic Reactions in Allergen Immunotherapy
‡9
2
|
|
919
|
|
|
‡a
europeansurveyonadversesystemicreactionsinallergenimmunotherapyeassiareallifeclinicalassessment
‡A
European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
‡9
1
|
|
919
|
|
|
‡a
evaluatingprimaryendpointsinpeanutimmunotherapyclinicaltrials
‡A
"Evaluating primary endpoints in peanut immunotherapy clinical trials"
‡9
1
|
|
919
|
|
|
‡a
exerciseinducedbronchospasmdiagnosisinchildrenutilityofcombinedlungfunctiontests
‡A
Exercise-induced bronchospasm diagnosis in children. Utility of combined lung function tests
‡9
1
|
|
919
|
|
|
‡a
freysyndromeinchildrenanonallergiccauseoffacialerythematriggeredbyfood
‡A
Frey syndrome in children: a nonallergic cause of facial erythema triggered by food
‡9
1
|
|
919
|
|
|
‡a
identificationofgapsintheclinicalpatientcareofasthmainspainresultsoftheoptimagemasurvey
‡A
[Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey].
‡9
1
|
|
919
|
|
|
‡a
initialexperiencewithcarboplatindesensitizationacaseseriesinapaediatrichospital
‡A
Initial experience with carboplatin desensitization: A case series in a paediatric hospital
‡9
1
|
|
919
|
|
|
‡a
misregulationofsuppressorsofcytokinesignalingineosinophilicesophagitis
‡A
Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis
‡9
1
|
|
919
|
|
|
‡a
occupationalasthmacausedbytheinhalationoftyrophagusputrescentiaeallergensinadrycuredhamtransporterallergictoshrimp
‡A
Occupational asthma caused by the inhalation of Tyrophagus putrescentiae allergens in a dry-cured ham transporter allergic to shrimp
‡9
1
|
|
919
|
|
|
‡a
oralimmunotherapyforfoodallergyaspanishguidelineeggandmilkimmunotherapyspanishguide
‡A
Oral immunotherapy for food allergy: a spanish guideline. Egg and Milk Immunotherapy Spanish Guide
‡9
1
|
|
919
|
|
|
‡a
oralimmunotherapyforfoodallergyaspanishguidelineeggandmilkimmunotherapyspanishguideitemsguidepart2
‡A
Oral immunotherapy for food allergy: a spanish guideline. Egg and Milk Immunotherapy Spanish Guide (items guide). Part II.
‡9
1
|
|
919
|
|
|
‡a
oralimmunotherapyforfoodallergyaspanishguidelineimmunotherapyeggandmilkspanishguideitemsguidepart1cowmilkandeggoralimmunotherapyintroductionmethodologyrationalecurrentstateindicationscontraindicationsandora
‡A
Oral immunotherapy for food allergy: A Spanish guideline. Immunotherapy egg and milk Spanish guide (items guide). Part I: Cow milk and egg oral immunotherapy: Introduction, methodology, rationale, current state, indications contraindications and ora
‡9
1
|
|
919
|
|
|
‡a
oralimmunotherapyinchildrenwithigemediatedwheatallergyoutcomeandmolecularchanges
‡A
Oral immunotherapy in children with IgE-mediated wheat allergy: outcome and molecular changes
‡9
1
|
|
919
|
|
|
‡a
oralimmunotherapytohakein8pediatricpatients
‡A
Oral Immunotherapy to Hake in 8 Pediatric Patients
‡9
1
|
|
919
|
|
|
‡a
physiciansexperienceandopiniononcontraindicationstoallergenimmunotherapytheconsitsurvey
‡A
Physicians' experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey.
‡9
1
|
|
919
|
|
|
‡a
possibleeosinophilicesophagitisinducedbymilkoralimmunotherapy
‡A
Possible eosinophilic esophagitis induced by milk oral immunotherapy
‡9
1
|
|
919
|
|
|
‡a
profilinachangeintheparadigm
‡A
Profilin, a change in the paradigm
‡9
1
|
|
919
|
|
|
‡a
prospectiveassessmentofdiagnostictestsforpediatricpenicillinallergyfromclinicalhistorytochallengetests
‡A
Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests
‡9
1
|
|
919
|
|
|
‡a
recommendationsforthestandardizationofclinicaloutcomesusedinallergenimmunotherapytrialsforallergicrhinoconjunctivitisaneaacipositionpaper
‡A
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
‡9
1
|
|
919
|
|
|
‡a
seriousadversereactiontotimololeyedropsina7yearoldboywithglaucomaandasthma
‡A
Serious Adverse Reaction to Timolol Eye Drops in a 7-Year-Old Boy With Glaucoma and Asthma
‡9
1
|
|
919
|
|
|
‡a
europeansurveyonadversesystemicreactionsinallergenimmunotherapyeassiapaediatricassessment
‡A
The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
LC|n 88076591
|
|
996
|
|
|
‡2
DNB|1159077797
|
|
996
|
|
|
‡2
CAOONL|ncf10709065
|
|
996
|
|
|
‡2
CAOONL|ncf11309085
|
|
996
|
|
|
‡2
BNC|981058517618806706
|
|
996
|
|
|
‡2
BIBSYS|90866501
|
|
996
|
|
|
‡2
NII|DA16778610
|
|
996
|
|
|
‡2
RERO|A003775637
|
|
996
|
|
|
‡2
ISNI|0000000059944488
|
|
996
|
|
|
‡2
NSK|000339732
|
|
996
|
|
|
‡2
DNB|116810688
|
|
996
|
|
|
‡2
BNE|XX1531014
|
|
996
|
|
|
‡2
SUDOC|143101943
|
|
996
|
|
|
‡2
BNE|XX1129920
|
|
996
|
|
|
‡2
LC|n 2014185790
|
|
996
|
|
|
‡2
J9U|987007275810605171
|
|
996
|
|
|
‡2
ISNI|0000000119928034
|
|
996
|
|
|
‡2
BNE|XX973167
|
|
996
|
|
|
‡2
NTA|143035282
|
|
996
|
|
|
‡2
BNE|XX885396
|
|
996
|
|
|
‡2
ISNI|0000000436053040
|
|
996
|
|
|
‡2
SUDOC|144881896
|
|
996
|
|
|
‡2
NTA|130171743
|
|
996
|
|
|
‡2
NUKAT|n 02032715
|
|
996
|
|
|
‡2
DNB|1163126357
|
|
996
|
|
|
‡2
ISNI|0000000116438304
|
|
996
|
|
|
‡2
BNE|XX1165471
|
|
996
|
|
|
‡2
RERO|A018325894
|
|
996
|
|
|
‡2
ISNI|0000000122643590
|
|
996
|
|
|
‡2
RERO|A003164923
|
|
996
|
|
|
‡2
PTBNP|1490494
|
|
996
|
|
|
‡2
NTA|323839878
|
|
996
|
|
|
‡2
CAOONL|ncf11546166
|
|
996
|
|
|
‡2
NUKAT|n 2009107243
|
|
996
|
|
|
‡2
LC|no2002080699
|
|
996
|
|
|
‡2
BNE|XX5186721
|
|
996
|
|
|
‡2
CAOONL|ncf11208060
|
|
996
|
|
|
‡2
LC|n 80089623
|
|
996
|
|
|
‡2
LC|n 2008032265
|
|
996
|
|
|
‡2
ISNI|0000000110471111
|
|
996
|
|
|
‡2
PTBNP|262793
|
|
996
|
|
|
‡2
SUDOC|080121241
|
|
996
|
|
|
‡2
SUDOC|087324237
|
|
996
|
|
|
‡2
BNF|16078287
|
|
996
|
|
|
‡2
PLWABN|9810613411805606
|
|
996
|
|
|
‡2
BNC|981061159539806706
|
|
996
|
|
|
‡2
ICCU|CUBV041123
|
|
996
|
|
|
‡2
SUDOC|236655515
|
|
996
|
|
|
‡2
BNE|XX5201471
|
|
996
|
|
|
‡2
LC|no2011077492
|
|
996
|
|
|
‡2
LC|no 93006818
|
|
996
|
|
|
‡2
BNE|XX1297564
|
|
996
|
|
|
‡2
ISNI|0000000059283608
|
|
996
|
|
|
‡2
SUDOC|075733862
|
|
996
|
|
|
‡2
NUKAT|n 2012061267
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
